Star Imaging and Path Lab Ltd (STARIMAGIN) is currently trading at 67.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Star Imaging and Path Lab Limited is an NABL and NABH accredited diagnostics operator providing integrated radiology, pathology, cardiology and neurology services across a network of 24 centres, operating B2G (government PPPs), B2C retail centres and B2B hospital partnerships primarily in Delhi, Uttar Pradesh and Nashik. FY26 performance showed modest top-line growth to INR88.5 crores (up 6%) while profitability expanded meaningfully; EBITDA grew to INR33.2 crores with a margin improvement of 330 basis points to 37.5%, and PAT rose 21% to INR19.3 crores, reflecting operating leverage from mix improvement and tighter cost control. The company is in an active roll-out phase with management guidance of INR20–25 crores capex for FY27, a marquee Dwarka centre requiring about INR14 crores capex and expected to generate INR5–6 crores initially, and a stated objective to deliver 25%–30% revenue growth in FY27 backed by these centre openings. Balance sheet and cash flows strengthened materially in FY26: operating cash flow improved to INR23.4 crores and the company reported net cash of around INR31 crores against total debt of INR20.6 crores, enabling self-funded capex and aggressive working capital normalisation efforts despite a sizable government receivable book of ~INR49.9 crores.

Over the past 52 weeks, Star Imaging and Path Lab Ltd has traded between a low of ₹46.00 and a high of ₹141.80. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Star Imaging and Path Lab Ltd has a market capitalization of approximately 117.32. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Star Imaging and Path Lab Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 6.88 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 117.32 Cr, Star Imaging and Path Lab Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Star Imaging and Path Lab Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Star Imaging and Path Lab Ltd is 6.88. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.